Victory Capital Management Inc. Acquires 777,038 Shares of Surgery Partners, Inc. (NASDAQ:SGRY)

Victory Capital Management Inc. boosted its holdings in Surgery Partners, Inc. (NASDAQ:SGRYFree Report) by 140.4% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,330,399 shares of the company’s stock after acquiring an additional 777,038 shares during the quarter. Victory Capital Management Inc. owned 1.05% of Surgery Partners worth $42,892,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the business. WCM Investment Management LLC increased its stake in Surgery Partners by 0.3% in the 3rd quarter. WCM Investment Management LLC now owns 522,084 shares of the company’s stock valued at $16,665,000 after buying an additional 1,819 shares during the last quarter. Versor Investments LP purchased a new position in shares of Surgery Partners in the 3rd quarter worth approximately $271,000. State of New Jersey Common Pension Fund D purchased a new position in shares of Surgery Partners in the 3rd quarter worth approximately $1,968,000. Principal Financial Group Inc. purchased a new position in shares of Surgery Partners in the 3rd quarter worth approximately $1,469,000. Finally, Cannon Global Investment Management LLC boosted its stake in shares of Surgery Partners by 61.1% in the 3rd quarter. Cannon Global Investment Management LLC now owns 29,000 shares of the company’s stock worth $935,000 after buying an additional 11,000 shares during the last quarter.

Surgery Partners Trading Down 7.3 %

Shares of SGRY stock opened at $22.95 on Friday. The company’s fifty day simple moving average is $30.62 and its two-hundred day simple moving average is $28.43. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.69. Surgery Partners, Inc. has a 1 year low of $22.25 and a 1 year high of $36.92. The stock has a market capitalization of $2.92 billion, a price-to-earnings ratio of -47.81, a PEG ratio of 18.74 and a beta of 2.76.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on SGRY. Cantor Fitzgerald restated an “overweight” rating and issued a $43.00 target price on shares of Surgery Partners in a research note on Friday, October 4th. Citigroup cut their target price on Surgery Partners from $38.00 to $36.00 and set a “buy” rating on the stock in a research note on Wednesday, August 7th. KeyCorp started coverage on Surgery Partners in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $49.00 price target on shares of Surgery Partners in a report on Wednesday, August 7th. Finally, Benchmark reaffirmed a “buy” rating and issued a $50.00 price target on shares of Surgery Partners in a report on Monday, August 26th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $40.71.

View Our Latest Research Report on Surgery Partners

Surgery Partners Company Profile

(Free Report)

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

Further Reading

Want to see what other hedge funds are holding SGRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Surgery Partners, Inc. (NASDAQ:SGRYFree Report).

Institutional Ownership by Quarter for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.